Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

CEL-SCI Corporation (CVM)

6.84   0.84 (14%) 07-15 16:00
Open: 6.18 Pre. Close: 6
High: 6.98 Low: 6
Volume: 1,005,169 Market Cap: 231M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.986 - 7.033 7.033 - 7.074
Low: 5.899 - 5.951 5.951 - 5.998
Close: 6.72 - 6.812 6.812 - 6.895

Technical analysis

as of: 2019-07-15 4:41:17 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 8.61     One year: 10.50
Support: Support1: 4.75    Support2: 3.95
Resistance: Resistance1: 7.37    Resistance2: 8.99
Pivot: 7.93
Moving Average: MA(5): 7.35     MA(20): 7.68
MA(100): 5.39     MA(250): 3.79
MACD: MACD(12,26): 0.33     Signal(9): 0.58
Stochastic oscillator: %K(14,3): 24.70     %D(3): 40.23
RSI: RSI(14): 47.45
52-week: High: 8.99  Low: 0.82  Change(%): 632.3
Average Vol(K): 3-Month: 98878  10-Days: 78427

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CVM has closed above bottom band by 13.6%. Bollinger Bands are 24.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 23 Jun 2019 14:07:33 Z
These 3 Biotech Stocks Skyrocketed Last Week -- Are They Buys Now?

Tue, 11 Sep 2018 16:47:57 Z
3 Small Biotech Stocks That Almost Doubled in Past Month

Fri, 07 Sep 2018 14:11:51 Z
Has Cel-Sci (CVM) Outpaced Other Medical Stocks This Year?

Fri, 31 Aug 2018 02:54:25 Z
Thursday Sector Leaders: Medical Instruments & Supplies, Biotechnology Stocks

Wed, 27 Jun 2018 20:08:02 Z
Wednesday Sector Laggards: Biotechnology, Drugs

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 29.77
Shares Float (M) 31.55
% Held by Insiders 5.41
% Held by Institutions 8.67
Shares Short (K) 3340
Shares Short P. Month (K)

Stock Financials

EPS -1.080
EPS Est. Current Year -0.420
EPS Est. Next Year -0.290
EPS Est. Next Quarter
Forward EPS 1.#IO
Book Value (p.s.) 0.030
PEG Ratio
Profit Margin
Operating Margin -3122.67
Return on Assets (ttm) -44.3
Return on Equity (ttm)
Qtrly Rev. Growth 31.9
Gross Profit (p.s.) -0.300
Sales Per Share
EBITDA (p.s.) -0.548
Qtrly Earnings Growth
Operating Cash Flow (M) -14.81
Levered Free Cash Flow (M) -12.51

Stock Valuations

P/E -6.31
P/E Growth Ratio 0.14
P/BV 227.00
P/S 10136684544.00
P/CF -13.69

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 1996-08-28
Forward Dividend
Last Split Date 2017-06-15
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.